__timestamp | Lantheus Holdings, Inc. | MiMedx Group, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 301600000 | 118223000 |
Thursday, January 1, 2015 | 293461000 | 187296000 |
Friday, January 1, 2016 | 301853000 | 245015000 |
Sunday, January 1, 2017 | 331378000 | 321139000 |
Monday, January 1, 2018 | 343374000 | 359111000 |
Tuesday, January 1, 2019 | 347337000 | 299255000 |
Wednesday, January 1, 2020 | 339410000 | 248234000 |
Friday, January 1, 2021 | 425208000 | 258615000 |
Saturday, January 1, 2022 | 935061000 | 267841000 |
Sunday, January 1, 2023 | 1296429000 | 321477000 |
Unlocking the unknown
In the ever-evolving landscape of the healthcare sector, Lantheus Holdings, Inc. and MiMedx Group, Inc. have showcased contrasting trajectories over the past decade. From 2014 to 2023, Lantheus Holdings has experienced a remarkable revenue growth, surging by over 330%, from approximately $300 million to nearly $1.3 billion. This growth underscores its strategic advancements and market adaptability. In contrast, MiMedx Group's revenue journey has been more turbulent, with a modest increase of around 170% over the same period, peaking at $359 million in 2018 before stabilizing around $321 million in 2023. This divergence highlights the dynamic nature of the industry, where innovation and strategic foresight can significantly impact a company's financial trajectory. As investors and stakeholders analyze these trends, the importance of agility and innovation in the healthcare sector becomes increasingly evident.
Revenue Insights: Genmab A/S and MiMedx Group, Inc. Performance Compared
Revenue Showdown: Sarepta Therapeutics, Inc. vs Lantheus Holdings, Inc.
Breaking Down Revenue Trends: Exelixis, Inc. vs MiMedx Group, Inc.
Lantheus Holdings, Inc. and Alkermes plc: A Comprehensive Revenue Analysis
Annual Revenue Comparison: Lantheus Holdings, Inc. vs Arrowhead Pharmaceuticals, Inc.
Revenue Insights: Lantheus Holdings, Inc. and Geron Corporation Performance Compared
Who Generates More Revenue? Lantheus Holdings, Inc. or Galapagos NV
Lantheus Holdings, Inc. vs MiMedx Group, Inc.: Efficiency in Cost of Revenue Explored
R&D Spending Showdown: Lantheus Holdings, Inc. vs MiMedx Group, Inc.
Comparing Revenue Performance: MorphoSys AG or MiMedx Group, Inc.?
Revenue Insights: ImmunityBio, Inc. and MiMedx Group, Inc. Performance Compared
Revenue Insights: BioCryst Pharmaceuticals, Inc. and MiMedx Group, Inc. Performance Compared